Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma. Pathak R, Salgia R. Clin Lung Cancer 2022;23:e137-e139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pathak R, Salgia R. Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma. Clin Lung Cancer 2022;23:e137-e139.
PMID: 34419376